OncoImmune Competitors and Similar CompaniesClear all
OncoImmune's competitors and similar companies include Leap Therapeutics, AstraZeneca, Telix Pharmaceuticals and NiKang Therapeutics.
 OncoImmune OncoImmune is a clinical-stage biopharmaceutical company engaged in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease. |  Leap Therapeutics Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care. |  NiKang Therapeutics NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines. | |
Founding Date | Founding Date 2000 | Founding Date 2011 | Founding Date 1999 | Founding Date 2015 | Founding Date 2017 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Rockville, US HQ | Locations Cambridge, US HQ | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Wilmington, US HQ | |
Employees | Employees 9 | Employees 688% decrease | Employees 94,300 | Employees 415 | Employees 403% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 176.4 m | Valuation ($) 2.7 b | Valuation ($) 4.6 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) $803.8m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $4.9b (FY, 2025) | Cost of goods $356m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $54.2b (FY, 2025) | Gross profit $449m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income $4.8m (FY, 2025) | Net income $10.2b (FY, 2025) | Net income ($7.1m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 71.8m | Total funding raised N/A | Total funding raised $ 1b | Total funding raised N/A | Total funding raised $ 200m |
For sources of this data, please see the company profile
View Company Profiles
Leap Therapeutics
HQ
Cambridge, US
Employees
6
Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyTelix Pharmaceuticals
HQ
North Melbourne, AU
Employees
415
Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.
View companyNiKang Therapeutics
HQ
Wilmington, US
Employees
40↑ 3% increase
NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.
View company